Monga, V.; Swami, U.; Tanas, M.; Bossler, A.; Mott, S.L.; Smith, B.J.; Milhem, M.
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas. Cancers 2018, 10, 53.
https://doi.org/10.3390/cancers10020053
AMA Style
Monga V, Swami U, Tanas M, Bossler A, Mott SL, Smith BJ, Milhem M.
A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas. Cancers. 2018; 10(2):53.
https://doi.org/10.3390/cancers10020053
Chicago/Turabian Style
Monga, Varun, Umang Swami, Munir Tanas, Aaron Bossler, Sarah L. Mott, Brian J. Smith, and Mohammed Milhem.
2018. "A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas" Cancers 10, no. 2: 53.
https://doi.org/10.3390/cancers10020053
APA Style
Monga, V., Swami, U., Tanas, M., Bossler, A., Mott, S. L., Smith, B. J., & Milhem, M.
(2018). A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas. Cancers, 10(2), 53.
https://doi.org/10.3390/cancers10020053